HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth

Hologic HOLX continues to experience strong momentum across its GYN Surgical portfolio, underscoring the increasing global focus on women’s health. The company’s investments in commercial and market access capabilities outside the United States have greatly expanded the reach of its minimally invasive surgical products, resulting in consistent success in the International unit. NovaSure, designed for the treatment of abnormal uterine bleeding,...